These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 6119861)
21. The pharmacology of experimental myopathies. Laskowski MB; Dettbarn WD Annu Rev Pharmacol Toxicol; 1977; 17():387-409. PubMed ID: 17357 [No Abstract] [Full Text] [Related]
22. [Bioamines of the sympathetic nervous system of the normal rat thyroid and in merkazolil exposure]. Vinogradov SIu Arkh Anat Gistol Embriol; 1987 Oct; 93(10):57-62. PubMed ID: 2449151 [TBL] [Abstract][Full Text] [Related]
23. [Electrolyte changes and mental disorders]. Villani F; Andreoli V; Mangoni A Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb; 96(1):7-31. PubMed ID: 4337777 [No Abstract] [Full Text] [Related]
24. Muscular dystrophy in the mouse: neuromuscular transmission and the concept of functional denervation. Harris JB; Ribchester RR Ann N Y Acad Sci; 1979; 317():152-70. PubMed ID: 38724 [TBL] [Abstract][Full Text] [Related]
25. Muscle regeneration in the muscular dystrophies. Nichols JR; Shafiq SA Ann N Y Acad Sci; 1979; 317():478-93. PubMed ID: 289326 [No Abstract] [Full Text] [Related]
26. Mechanisms of resistance to pathogenesis in muscular dystrophies. Infante JP; Huszagh VA Mol Cell Biochem; 1999 May; 195(1-2):155-67. PubMed ID: 10395079 [TBL] [Abstract][Full Text] [Related]
27. [Erythrocytic membrane. II. Changes in progressive muscular dystrophies]. Delaunay J; Fischer S Nouv Presse Med; 1977 Apr; 6(13):1129-36. PubMed ID: 850625 [No Abstract] [Full Text] [Related]
28. Catecholamines and indoleamines in patients with Duchenne muscular dystrophy. Mendell JR; Murphy DL; Engel WK; Chase TN; Gordon E Arch Neurol; 1972 Dec; 27(6):518-20. PubMed ID: 5083869 [No Abstract] [Full Text] [Related]
30. Functional studies of reeenerated muscles from normal and dystrophic mice. Salafsky B Nature; 1971 Jan; 229(5282):270-2. PubMed ID: 4927202 [No Abstract] [Full Text] [Related]
31. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Campbell KP Cell; 1995 Mar; 80(5):675-9. PubMed ID: 7889563 [No Abstract] [Full Text] [Related]
32. [Research on the molecular mechanisms of the pathogenesis of myodystrophies and the systematic approach to the study of human proteins (a review)]. Shishkin SS; Kovalev LI Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(3):119-23. PubMed ID: 3289286 [No Abstract] [Full Text] [Related]
33. [Characteristics of lipid metabolism of the skeletal muscles in progressive muscular dystrophy]. Badalian LO; Grinio LP; Temin PA; Islamova IB; Il'in IL Pediatriia; 1983 Jan; (1):66-8. PubMed ID: 6340057 [No Abstract] [Full Text] [Related]
34. On the pathogenesis of duchenne muscular dystrophy. Fenichel GM Dev Med Child Neurol; 1975 Aug; 17(4):527-33. PubMed ID: 169179 [TBL] [Abstract][Full Text] [Related]
36. An electron microscopical study of the T-system in biopsied muscles from Fukuyama type congenital muscular dystrophy. Miike T; Ohtani Y; Tamari H; Ishitsu T; Nonaka I Muscle Nerve; 1984 Oct; 7(8):629-35. PubMed ID: 6543909 [TBL] [Abstract][Full Text] [Related]
37. Considerations about a possible role played by connective tissue proliferation and vascular disturbances in the pathogenesis of progressive muscular dystrophy. Cazzato G Eur Neurol; 1968; 1(3):158-79. PubMed ID: 5698619 [No Abstract] [Full Text] [Related]
38. Pathophysiology of muscular dystrophy. Partridge T Br J Hosp Med; 1993 Jan 6-19; 49(1):26-36. PubMed ID: 8431724 [TBL] [Abstract][Full Text] [Related]
39. Using electromyography to assess function in humans and animal models of muscular dystrophy. Han JJ; Carter GT; Weiss MD; Shekar C; Kornegay JN Phys Med Rehabil Clin N Am; 2005 Nov; 16(4):981-97, x. PubMed ID: 16214055 [No Abstract] [Full Text] [Related]
40. [Neurohumoral changes in acute intestinal obstruction]. Rybachkov VV; Maĭorov MI; Makanov OA Vestn Khir Im I I Grek; 2005; 164(1):25-8. PubMed ID: 15957804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]